Literature DB >> 24669311

Thermal and resonance neutrons generated by various electron and X-ray therapeutic beams from medical linacs installed in polish oncological centers.

Adam Konefał1, Andrzej Orlef2, Marcin Laciak3, Aleksander Ciba4, Marek Szewczuk2.   

Abstract

BACKGROUND: High-energy photon and electron therapeutic beams generated in medical linear accelerators can cause the electronuclear and photonuclear reactions in which neutrons with a broad energy spectrum are produced. A low-energy component of this neutron radiation induces simple capture reactions from which various radioisotopes originate and in which the radioactivity of a linac head and various objects in the treatment room appear. AIM: The aim of this paper is to present the results of the thermal/resonance neutron fluence measurements during therapeutic beam emission and exemplary spectra of gamma radiation emitted by medical linac components activated in neutron reactions for four X-ray beams and for four electron beams generated by various manufacturers' accelerators installed in typical concrete bunkers in Polish oncological centers.
MATERIALS AND METHODS: The measurements of neutron fluence were performed with the use of the induced activity method, whereas the spectra of gamma radiation from decays of the resulting radioisotopes were measured by means of a portable high-purity germanium detector set for field spectroscopy.
RESULTS: The fluence of thermal neutrons as well as resonance neutrons connected with the emission of a 20 MV X-ray beam is ∼10(6) neutrons/cm(2) per 1 Gy of a dose in water at a reference depth. It is about one order of magnitude greater than that for the 15 MV X-ray beams and about two orders of magnitude greater than for the 18-22 MeV electron beams regardless of the type of an accelerator.
CONCLUSION: The thermal as well as resonance neutron fluence depends strongly on the type and the nominal potential of a therapeutic beam. It is greater for X-ray beams than for electrons. The accelerator accessories and other large objects should not be stored in a treatment room during high-energy therapeutic beam emission to avoid their activation caused by thermal and resonance neutrons. Half-lives of the radioisotopes originating from the simple capture reaction (n,γ) (from minutes to hours) are long enough to accumulate radioactivity of components of the accelerator head. The radiation emitted by induced radioisotopes causes the additional doses to staff operating the accelerators.

Entities:  

Keywords:  Induce radioactivity; Medical linacs; Thermal/resonance neutrons

Year:  2012        PMID: 24669311      PMCID: PMC3920349          DOI: 10.1016/j.rpor.2012.06.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  11 in total

1.  Induced radioactive potential for a medical accelerator.

Authors:  Victor Evdokimoff; John Willins; Hans Richter
Journal:  Health Phys       Date:  2002-11       Impact factor: 1.316

2.  Health physics aspects of neutron activated components in a linear accelerator.

Authors:  Shuntong Guo; Paul L Ziemer
Journal:  Health Phys       Date:  2004-05       Impact factor: 1.316

3.  A study of neutron spectra from medical linear accelerators.

Authors:  A Facure; R C Falcão; A X Silva; V R Crispim; J C Vitorelli
Journal:  Appl Radiat Isot       Date:  2005-01       Impact factor: 1.513

4.  Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.

Authors:  Stephen F Kry; Mohammad Salehpour; David S Followill; Marilyn Stovall; Deborah A Kuban; R Allen White; Isaac I Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

5.  Activation processes in a medical linear accelerator and spatial distribution of activation products.

Authors:  Helmut W Fischer; Ben E Tabot; Björn Poppe
Journal:  Phys Med Biol       Date:  2006-11-30       Impact factor: 3.609

6.  Correlation between radioactivity induced inside the treatment room and the undesirable thermal/resonance neutron radiation produced by linac.

Authors:  Adam Konefał; Andrzej Orlef; Marcin Dybek; Zbigniew Maniakowski; Kinga Polaczek-Grelik; Wiktor Zipper
Journal:  Phys Med       Date:  2008-03-12       Impact factor: 2.685

7.  Slow-neutron detection by foils--II.

Authors:  C W TITTLE
Journal:  Nucleonics       Date:  1951-07

Review 8.  A review on photoneutrons characteristics in radiation therapy with high-energy photon beams.

Authors:  Alireza Naseri; Asghar Mesbahi
Journal:  Rep Pract Oncol Radiother       Date:  2010-09-22

9.  Undesirable nuclear reactions and induced radioactivity as a result of the use of the high-energy therapeutic beams generated by medical linacs.

Authors:  Adam Konefal; Kinga Polaczek-Grelik; Wiktor Zipper
Journal:  Radiat Prot Dosimetry       Date:  2007-06-14       Impact factor: 0.972

10.  Air activation produced by high-energy medical accelerators.

Authors:  P H McGinley; T A White
Journal:  Med Phys       Date:  1983 Nov-Dec       Impact factor: 4.071

View more
  4 in total

1.  MC safe bunker designing for an 18 MV linac with nanoparticles included primary barriers and effect of the nanoparticles on the shielding aspects.

Authors:  Amir Ghasemi-Jangjoo; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-06

2.  Application of the phase-space distribution approach of Monte Carlo for radiation contamination dose estimation from the (n,γ), (γ,n) nuclear reactions and linac leakage photons in the megavoltage radiotherapy facility.

Authors:  Amir Ghasemi-Jangjoo; Hosein Ghiasi
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-24

3.  Monte Carlo calculation of photo-neutron dose produced by circular cones at 18 MV photon beams.

Authors:  Elham Hosseinzadeh; Nooshin Banaee; Hassan Ali Nedaie
Journal:  Rep Pract Oncol Radiother       Date:  2018-01-09

4.  Neutron and high energy photon fluence estimation in CLINAC using gold activation foils.

Authors:  Kh Haddad; O Anjak; B Yousef
Journal:  Rep Pract Oncol Radiother       Date:  2018-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.